Search for: "Merck/Schering-Plough Pharmaceuticals" Results 1 - 20 of 72
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2021, 9:52 am by Tim De Chant
Yesterday, the court heard that Holmes did it once more, sending reports that prominently featured the logo of Schering-Plough, the large pharmaceutical company that was acquired by Merck in 2009. [read post]
22 Mar 2018, 1:23 pm by bcutterlaw
Shortly thereafter Schering-Plough Corporation merged with Merck & Company, Inc., who kept Solis on in his same role for a year before firing him. [read post]
20 Mar 2018, 7:27 am by Joy Waltemath
The employee, a former sales representative for three firms (Millennium Pharmaceuticals, Schering-Plough, and Merck), filed the original action in 2009, alleging violations of state law and the FCA for promoting off-label uses of Integrilin, and paying kickbacks to physicians for prescribing Integrilin and Avelox. [read post]
29 May 2014, 1:40 pm by RatnerPrestia
He has handled complex pharmaceutical and biotech patent cases throughout his career, most recently specializing in global patent litigation and IP licensing at Merck and Schering-Plough. [read post]
6 Mar 2014, 12:41 pm
 Thus FDA-approved statements have been exempted from consumer protection/fraud liability:The pharmaceutical industry is highly regulated, both at the federal level and internationally. [read post]
5 Mar 2014, 2:46 pm
Schering-Plough Corp., California Supreme Court – existence of “presumption of reliance” in consumer fraud class actions·                     Caldwell v. [read post]
25 Feb 2014, 2:49 pm
Its former U.S. affiliate became then the company Schering-Plough. [read post]
18 Dec 2013, 2:13 pm by Tom Lamb
The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
15 Feb 2013, 2:05 pm by Lyle Roberts
The case is actually two cases - against Merck and Schering-Plough Corp.... [read post]
24 Oct 2012, 10:02 am by Tom Lamb
Since that time, first, Organon was acquired by Schering-Plough and, later, Merck took over Schering-Plough and Organon. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]
24 Aug 2012, 7:46 pm by Lyle Denniston
  A Merck subsidiary, Key Pharmaceuticals, Inc., has been assigned the patent, which was set to expire on September 5, 2006. [read post]
30 May 2012, 1:37 pm by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
14 Apr 2012, 11:13 am
Dawn Kregel, a nurse, filed suit against Organon USA Inc., Organon Pharmaceuticals USA Inc., Organon International Inc., Schering-Plough Corp. and Merck & Co. [read post]